These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds. Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221 [TBL] [Abstract][Full Text] [Related]
27. DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China. Zhang M; Zhang L; Zhang C; Hong K; Shao Y; Huang Z; Wang S; Lu S Hum Vaccin Immunother; 2012 Nov; 8(11):1630-7. PubMed ID: 23111170 [TBL] [Abstract][Full Text] [Related]
28. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop. Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999 [TBL] [Abstract][Full Text] [Related]
29. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833 [TBL] [Abstract][Full Text] [Related]
30. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States. Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588 [TBL] [Abstract][Full Text] [Related]
31. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies. von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574 [TBL] [Abstract][Full Text] [Related]
33. The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses. Ringel O; Vieillard V; Debré P; Eichler J; Büning H; Dietrich U Viruses; 2018 Apr; 10(4):. PubMed ID: 29662026 [TBL] [Abstract][Full Text] [Related]
34. What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure? Alexander MR; Ringe R; Sanders RW; Voss JE; Moore JP; Klasse PJ J Virol; 2015 Jun; 89(11):5981-95. PubMed ID: 25810537 [TBL] [Abstract][Full Text] [Related]
35. Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design. Rantalainen K; Berndsen ZT; Murrell S; Cao L; Omorodion O; Torres JL; Wu M; Umotoy J; Copps J; Poignard P; Landais E; Paulson JC; Wilson IA; Ward AB Cell Rep; 2018 Jun; 23(11):3249-3261. PubMed ID: 29898396 [TBL] [Abstract][Full Text] [Related]
36. Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. Sliepen K; Han BW; Bontjer I; Mooij P; Garces F; Behrens AJ; Rantalainen K; Kumar S; Sarkar A; Brouwer PJM; Hua Y; Tolazzi M; Schermer E; Torres JL; Ozorowski G; van der Woude P; de la Peña AT; van Breemen MJ; Camacho-Sánchez JM; Burger JA; Medina-Ramírez M; González N; Alcami J; LaBranche C; Scarlatti G; van Gils MJ; Crispin M; Montefiori DC; Ward AB; Koopman G; Moore JP; Shattock RJ; Bogers WM; Wilson IA; Sanders RW Nat Commun; 2019 May; 10(1):2355. PubMed ID: 31142746 [TBL] [Abstract][Full Text] [Related]
37. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study. Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681 [TBL] [Abstract][Full Text] [Related]
38. Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses. Perdiguero B; Gómez CE; García-Arriaza J; Sánchez-Corzo C; Sorzano CÓS; Wilmschen S; von Laer D; Asbach B; Schmalzl C; Peterhoff D; Ding S; Wagner R; Kimpel J; Levy Y; Pantaleo G; Esteban M Front Immunol; 2019; 10():2941. PubMed ID: 31921191 [TBL] [Abstract][Full Text] [Related]
39. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity. Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566 [TBL] [Abstract][Full Text] [Related]
40. Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin. Ringe RP; Cruz Portillo VM; Dosenovic P; Ketas TJ; Ozorowski G; Nogal B; Perez L; LaBranche CC; Lim J; Francomano E; Wilson IA; Sanders RW; Ward AB; Montefiori DC; Nussenzweig MC; Klasse PJ; Cupo A; Moore JP J Virol; 2020 Feb; 94(6):. PubMed ID: 31852794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]